General Information
Revision date
2017-02-01
Product name
Albuterol Sulfate Inhalation Solution, 0.5%*
Product Synonyms
Benzyl alcohol derivative
Chemical name
α 1-[tert-butylamino)-methyl]-4-hydroxy-m-xylene- α - α"-diol sulfate (2:1) (salt)
CAS No.
51022-70-9
Icons in SDS
Company Information
company name
Nephron Pharmaceuticals Corporation
Section 2
SECTION 2: Hazards identification
The following adverse effects have been reported with medicinal use of Albuterol Sulfate Inhalation Solution, 0.5 and may accompany unintentional exposure in sufficient dose: fine muscle tremors, muscle cramps, nausea/vomiting, headache, dizziness, nervousness, heartburn, and rapid pulse, palpitations, and increased blood pressure. Extremely rapid heartbeat, seizures, low serum potassium levels, and worsening of the symptoms of pre-existent cardiovascular (heart and blood vessel) conditions and diabetes are possible. Hypersensitivity reactions such as hives, skin rash, constriction of the air passages in the lungs, and swelling involving the skin and mucous membranes have been reported. (See Section 11, “Toxicological Information”)
